A double-blind, placebo-controlled, randomized phase II pilot study to investigate the potential efficacy of the traditional Chinese medicine neuroaid (MLC 601) in enhancing recovery after stroke (TIERS)
10.1159/000247001
Saved in:
Main Authors: | Kong, K.H., Wee, S.K., Ng, C.Y., Chua, K., Chan, K.F., Venketasubramanian, N., Chen, C. |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
2016
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/129779 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
NeuroAid II (MLC901) in Haemorrhagic Stroke
by: Chai-Hoon Nowel Tan, et al.
Published: (2021) -
Frequency and Clinical Impact of Serious Adverse Events on Post-Stroke Recovery with NeuroAiD (MLC601) versus Placebo: The CHInese Medicine Neuroaid Efficacy on Stroke Recovery Study
by: Venketasubramanian, Narayanaswamy, et al.
Published: (2021) -
Efficacy and safety of MLC601 (NeuroAiD®), a traditional chinese medicine, in poststroke recovery: A systematic review
by: Siddiqui, F.J., et al.
Published: (2014) -
Safety profile of MLC601 (Neuroaid®) in acute ischemic stroke patients: A Singaporean substudy of the chinese medicine neuroaid efficacy on stroke recovery study
by: Young, S.H.Y., et al.
Published: (2011) -
NEURoaid II (MLC901) in cognitively Impaired not demenTEd patientS (NEURITES): A pilot double blind, placebo-controlled randomized trial
by: Chen, CLH, et al.
Published: (2022)